Scientists have noticed something about empagliflozin which could benefit both non-diabetic and diabetic heart failure patients.
The drug was found to prolong the survival of people with Type 2 diabetes may also be able to treat heart failure.
— Read on www.mirror.co.uk/lifestyle/health/dr-miriam-stoppard-wonder-diabetes-18209013